Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2025-12-24 @ 2:45 PM
NCT ID:
NCT01326559
Eligibility Criteria:
Inclusion criteria:
* Recurrent T3N0-N1M0 NPC (by AJCC/UICC 6th edition) and at least 1 year from the end of last primary course of radiotherapy
* Age \> 18 to \< 70 years
* Performance status: \< 1 by ECOG System (Appendix I)
* Adequate bone marrow \& renal function
* Patients having Bilirubin =\< 1.5 x ULN, ASAT \& ALST=\< 1.5 x ULN, Serum creatinine=\< 1.25 x ULN and / or Creatinine clearance \>= 60ml/min
* Patients having WBC \>= 3x10e9/L, Neutrophils 1.8x10e9/L, Platelets \>= 100 x10e9/L,Hemoglobin \>=10g/dL
* Signed written informed consent
* Patients must have at least one measurable lesion
Exclusion Criteria:
* Use of investigational agent within the past 28 days
* Pre-treatment with an anti-EGFR drug
* Severe cardiac disease such as heart failure, coronary artery disease or myocardial infarction within the last 12 months
* History of severe pulmonary diseases
* Active infection or other systemic disease under poor control
* Uncontrolled chronic neuropathy
* Know grade 3 or 4 allergic reaction to any of the components of the treatment
* Estimated life expectancy is less than 3 months
* Pregnancy or breast feeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT01326559
Study Brief:
Protocol Section:
NCT01326559